Evogene Ltd. (EVGN)
1.11
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
Evogene EPS Diluted (Quarterly): 0.4444 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediWound Ltd. | -0.2406 |
| Nano-X Imaging Ltd. | -0.2127 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.729M |
| Revenue (Quarterly) | 0.312M |
| Total Expenses (Quarterly) | 4.364M |
| Enterprise Value | 12.35M |
| Gross Profit Margin (Quarterly) | -40.38% |
| Profit Margin (Quarterly) | -874.7% |
| Earnings Yield | -44.22% |
| Normalized Earnings Yield | -44.22 |